383 related articles for article (PubMed ID: 35996075)
1. High expression of cuproptosis-related SLC31A1 gene in relation to unfavorable outcome and deregulated immune cell infiltration in breast cancer: an analysis based on public databases.
Li L; Li L; Sun Q
BMC Bioinformatics; 2022 Aug; 23(1):350. PubMed ID: 35996075
[TBL] [Abstract][Full Text] [Related]
2. Identification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancer.
Wu JH; Cheng TC; Zhu B; Gao HY; Zheng L; Chen WX
Sci Rep; 2023 Oct; 13(1):18390. PubMed ID: 37884650
[TBL] [Abstract][Full Text] [Related]
3. Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in glioma.
Wang J; Li S; Guo Y; Zhao C; Chen Y; Ning W; Yang J; Zhang H
Funct Integr Genomics; 2023 Aug; 23(3):279. PubMed ID: 37610668
[TBL] [Abstract][Full Text] [Related]
4. Cuproptosis-related gene SLC31A1 is a potential predictor for diagnosis, prognosis and therapeutic response of breast cancer.
Li X; Ma Z; Mei L
Am J Cancer Res; 2022; 12(8):3561-3580. PubMed ID: 36119835
[TBL] [Abstract][Full Text] [Related]
5. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
[TBL] [Abstract][Full Text] [Related]
6. Cuproptosis-related gene SLC31A1: prognosis values and potential biological functions in cancer.
Qi Y; Yao Q; Li X; Li X; Zhang W; Qu P
Sci Rep; 2023 Oct; 13(1):17790. PubMed ID: 37853210
[TBL] [Abstract][Full Text] [Related]
7. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
8. A ceRNA network-mediated over-expression of cuproptosis-related gene SLC31A1 correlates with poor prognosis and positive immune infiltration in breast cancer.
Lian W; Yang P; Li L; Chen D; Wang C
Front Med (Lausanne); 2023; 10():1194046. PubMed ID: 37275369
[TBL] [Abstract][Full Text] [Related]
9. Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types.
Kong FS; Ren CY; Jia R; Zhou Y; Chen JH; Ma Y
BMC Med Genomics; 2023 Mar; 16(1):61. PubMed ID: 36973786
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer.
Pan Y; Zhang Q; Zhang H; Kong F
Funct Integr Genomics; 2023 Jan; 23(1):38. PubMed ID: 36640225
[TBL] [Abstract][Full Text] [Related]
11. Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer.
Mi J; Luo J; Zeng H; Zhang H; Jamil M; Abdel-Maksoud MA; Zakri AM; Alfuraydi AA; Zhang N; Xiao M
Am J Transl Res; 2023; 15(10):6026-6041. PubMed ID: 37969191
[TBL] [Abstract][Full Text] [Related]
12. Revealing the potential of solute carrier family 31 (copper transporters), member 1: Insights into its role in bladder cancer progression and therapeutic implications.
Lin YZ; Liu WH; Wu YP; Cai H; Zheng QS; Wei Y; Xu N; Xue XY
Int J Immunopathol Pharmacol; 2024; 38():3946320241240706. PubMed ID: 38712735
[No Abstract] [Full Text] [Related]
13. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set.
Liu H; Tang T
Front Oncol; 2022; 12():952290. PubMed ID: 36276096
[TBL] [Abstract][Full Text] [Related]
14. ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury.
Huo S; Wang Q; Shi W; Peng L; Jiang Y; Zhu M; Guo J; Peng D; Wang M; Men L; Huang B; Lv J; Lin L
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675183
[TBL] [Abstract][Full Text] [Related]
15. Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer.
Zhou C; Li C; Zheng Y; Huang X
Front Oncol; 2022; 12():934076. PubMed ID: 36387247
[TBL] [Abstract][Full Text] [Related]
16. Cuproptosis-related lncRNAs ovarian cancer: Multi-omics analysis of molecular mechanisms and potential therapeutic targets.
Wang Y; Liang Q; Xu L; Xiong J; Gao K; Xu P; Huang W
Environ Toxicol; 2024 Mar; 39(3):1650-1665. PubMed ID: 38019212
[TBL] [Abstract][Full Text] [Related]
17. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer.
Jiang B; Zhu H; Feng W; Wan Z; Qi X; He R; Xie L; Li Y
Dis Markers; 2022; 2022():9004830. PubMed ID: 36312586
[TBL] [Abstract][Full Text] [Related]
18. Copper-related genes predict prognosis and characteristics of breast cancer.
Liu Y; Wang J; Jiang M
Front Immunol; 2023; 14():1145080. PubMed ID: 37180167
[TBL] [Abstract][Full Text] [Related]
19. Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma.
Chen X; Hu G; Xiong L; Xu Q
Pathol Oncol Res; 2022; 28():1610558. PubMed ID: 36213162
[No Abstract] [Full Text] [Related]
20. Identification of a Novel Cuproptosis-Related Gene Signature and Integrative Analyses in Thyroid Cancer.
Huang J; Shi J; Wu P; Sun W; Zhang D; Wang Z; Ji X; Lv C; Zhang T; Zhang P; Zhang H
J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
